APPLICATION
ANDA091073
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-18
LATEST ACTION
2024-02-07
ROUTE
TRANSDERMAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
TESTOSTERONEPrescription
TESTOSTERONE 50MG/5GM PACKET · GEL · TRANSDERMAL
Approval history
2024-02-07Labeling · Supplement 3 · standardAP
2024-02-07Labeling · Supplement 6 · standardAP
2019-06-21Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.